Young-Ger Suh - Search Results

Year	Number of Results
2002	4
2003	8
2004	8
2005	8
2006	4
2007	7
2008	4
2009	8
2010	6
2011	9
2012	10
2013	4
2014	11
2015	15
2016	6
2017	7
2018	14
2019	7
2020	8
2021	12
2022	2
2023	2
2024	2

1

Diastereoselective Total Synthesis of (-)-Galiellalactone.

Kim T, Han YT, An H, Kim K, Lee J, Suh YG. Kim T, et al. Among authors: suh yg. J Org Chem. 2015 Dec 18;80(24):12193-200. doi: 10.1021/acs.joc.5b02121. Epub 2015 Nov 13. J Org Chem. 2015. PMID: 26544529

2

Stereoselective synthesis of 7-epi-incarvilline.

Seo H, Yun H, Lee S, Jang J, Han YT, Kim DD, Lee J, Suh YG. Seo H, et al. Among authors: suh yg. Org Lett. 2013 Feb 1;15(3):531-3. doi: 10.1021/ol303395f. Epub 2013 Jan 23. Org Lett. 2013. PMID: 23343424

3

Cationic complex: (99m)Tc-N,N'-dimethyldiaminedithiol.

Jeong JM, Lee YS, Joo Kim Y, Soo Lee D, Chung JK, Suh YG, Chul Lee M. Jeong JM, et al. Among authors: suh yg. Nucl Med Biol. 2002 Aug;29(6):711-7. doi: 10.1016/s0969-8051(02)00312-8. Nucl Med Biol. 2002. PMID: 12234598

4

RKIP Induction Promotes Tumor Differentiation via SOX2 Degradation in NF2-Deficient Conditions.

Cho JH, Park S, Kim S, Kang SM, Woo TG, Yoon MH, Lee H, Jeong M, Park YH, Kim H, Han YT, Suh YG, Kim BH, Kwon Y, Yun H, Park BJ. Cho JH, et al. Among authors: suh yg. Mol Cancer Res. 2022 Mar 1;20(3):412-424. doi: 10.1158/1541-7786.MCR-21-0373. Mol Cancer Res. 2022. PMID: 34728553

5

Allosteric regulation of pathologic angiogenesis: potential application for angiogenesis-related blindness.

Jo DH, Kim JH, Kim KW, Suh YG, Kim JH. Jo DH, et al. Among authors: suh yg. Arch Pharm Res. 2014 Mar;37(3):285-98. doi: 10.1007/s12272-013-0324-y. Epub 2014 Jan 7. Arch Pharm Res. 2014. PMID: 24395531 Review.

6

Discovery of new ERRγ agonists regulating dopaminergic neuronal phenotype in SH-SY5Y cells.

Kim T, Kim HI, Oh H, Jeon Y, Shin H, Kim HS, Lim J, Lim C, Yoo J, Suh YG, Son WS, Choi HJ, Kim SH. Kim T, et al. Among authors: suh yg. Bioorg Chem. 2022 May;122:105716. doi: 10.1016/j.bioorg.2022.105716. Epub 2022 Mar 11. Bioorg Chem. 2022. PMID: 35303621

7

Light-regulated tetracycline binding to the Tet repressor.

Moon J, Gam J, Lee SG, Suh YG, Lee J. Moon J, et al. Among authors: suh yg. Chemistry. 2014 Feb 24;20(9):2508-14. doi: 10.1002/chem.201304027. Epub 2014 Jan 29. Chemistry. 2014. PMID: 24478132

8

Activation and activators of TRPV1 and their pharmaceutical implication.

Suh YG, Oh U. Suh YG, et al. Curr Pharm Des. 2005;11(21):2687-98. doi: 10.2174/1381612054546789. Curr Pharm Des. 2005. PMID: 16101449 Review.

9

Novel C6-substituted 1,3,4-oxadiazinones as potential anti-cancer agents.

Alam MM, Lee SC, Jung Y, Yun HJ, Min HY, Lee HJ, Pham PC, Moon J, Kwon DI, Lim B, Suh YG, Lee J, Lee HY. Alam MM, et al. Among authors: suh yg. Oncotarget. 2015 Dec 1;6(38):40598-610. doi: 10.18632/oncotarget.5839. Oncotarget. 2015. PMID: 26515601 Free PMC article.

10

ERRγ ligand HPB2 upregulates BDNF-TrkB and enhances dopaminergic neuronal phenotype.

Kim HI, Lee S, Lim J, Chung S, Koo TS, Ji YG, Suh YG, Son WS, Kim SH, Choi HJ. Kim HI, et al. Among authors: suh yg. Pharmacol Res. 2021 Mar;165:105423. doi: 10.1016/j.phrs.2021.105423. Epub 2021 Jan 9. Pharmacol Res. 2021. PMID: 33434621

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

156 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

156 results

Results by year